Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nemaura Medical Inc (NQ: NMRD ) 0.1053 UNCHANGED Last Price Updated: 4:00 PM EST, Jan 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nemaura Medical Inc < Previous 1 2 3 4 5 6 7 8 9 Next > BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at H.C. Wainwright Bioconnect Conference January 07, 2022 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Marks True Milestone in Development, Growth January 04, 2022 Via Investor Brand Network Nemaura Medical Solutions Empowering People to Take Charge of Well-Being December 29, 2021 Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized... Via Benzinga Nemaura Medical (NASDAQ: NMRD) Solutions Empowering People to Take Charge of Well-Being December 29, 2021 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Solutions to Empower People to Take Charge of Their Health, Well-Being December 29, 2021 Via Investor Brand Network Nemaura Medical Complete Initial Shipment of sugarBEAT(R) Devices to UK Licensee December 23, 2021 Nemaura Medical announced the successful completion of its initial shipment of sugarBEAT(R) continuous glucose monitor devices to its UK licensee The initial shipment, which... Via Benzinga Nemaura Medical (NASDAQ: NMRD) Complete Initial Shipment of sugarBEAT(R) Devices to UK Licensee December 23, 2021 Via Investor Brand Network Nemaura Medical Inc. (NASDAQ: NMRD) Complete Initial Shipment of sugarBEAT(R) Devices to UK Licensee December 22, 2021 Via Investor Brand Network Nemaura Medical Positioned to Benefit from Growth in CGM Market December 14, 2021 Nemaura Medical (NASDAQ: NMRD) has developed a platform to monitor multiple chemicals in the blood without needles, replacing traditional invasive methods of diagnosis and health... Via Benzinga Nemaura Medical (NASDAQ: NMRD) Positioned to Benefit from Growth in CGM Market December 14, 2021 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Positioned to Benefit from Growth in CGM Market December 13, 2021 Via Investor Brand Network 54 Biggest Movers From Yesterday December 08, 2021 Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and... Via Benzinga BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Initial Shipment of CGM Devices to MySugarWatch Licensee December 07, 2021 Via Investor Brand Network Nemaura Medical Inc. (NASDAQ: NMRD) Helping Diabetic Individuals Safeguard Themselves From COVID-19 December 07, 2021 Via Investor Brand Network Topics Death Exposures COVID-19 Death Nemaura Medical Releases Q2-2021 Results, Signs Global Commercial Contract December 02, 2021 NMRD releases fiscal Q2-2021 results, provides business update Highlights include pending revenue recognition, global commercial contract with MySugarWatch DuoPack Limited, the... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2021 December 02, 2021 Upgrades According to William Blair, the prior rating for Graco Inc (NYSE: Via Benzinga Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q2-2021 Results, Signs Global Commercial Contract with MySugarWatch DuoPack Limited December 02, 2021 Via Investor Brand Network Nemaura Medical CEO to Present at Upcoming Conference December 01, 2021 Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized... Via Benzinga BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) CEO to Present at Benzinga Global Small Cap Conference November 30, 2021 Via Investor Brand Network Nemaura Medical Offers 'First-of-a-Kind' Device in Growing CGM Market November 18, 2021 The global continuous glucose monitoring devices market size is expected to reach $19.04 billion in 2028 The increasing prevalence of diabetes, rising focus on preventive care... Via Benzinga Nemaura Medical Inc. (NASDAQ: NMRD) Offers ‘First-of-a-Kind’ Device in Growing CGM Market November 18, 2021 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q2 2022 Financial, Business Report November 15, 2021 Via Investor Brand Network InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q2 2022 Financial, Business Report November 15, 2021 Via Investor Brand Network Nemaura Medical Inc. Extending Tech, Programs Beyond Traditional Diabetes Market November 10, 2021 Nemaura Medical (NASDAQ: NMRD), a cutting-edge medical technology company, recently conducted the beta launch of MiBoKo, a new proprietary metabolic health program designed to... Via Benzinga BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Extending Proprietary Technology, Programs Beyond Traditional Diabetes Market November 09, 2021 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Nemaura Medical Inc. Announces Participation at Diabetes Technology Society Conference November 04, 2021 Nemaura Medical (NASDAQ: NMRD) CEO Faz Chowdhury, PhD, will be presenting at annual meeting of the Diabetes Technology Society. The two-day meeting is slated for Nov. 5–6,... Via Benzinga InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at Diabetes Technology Society Conference November 04, 2021 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Stands Distinct in Patient Support October 28, 2021 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Facilitating Improved Diabetes and Prediabetes Management October 22, 2021 Via Investor Brand Network Nemaura Medical Inc. (NASDAQ: NMRD) Announce Beta Launch of Proprietary ‘MiBoKo’ Metabolic Health Program October 18, 2021 Via Investor Brand Network < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.